Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126229021 | 12622902 | 1 | I | 20160318 | 20160726 | 20160804 | 20160804 | EXP | US-TEVA-680385USA | TEVA | 16.45 | YR | F | Y | 45.85000 | KG | 20160804 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126229021 | 12622902 | 1 | PS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | Y | 81099 | ||||||||||
| 126229021 | 12622902 | 2 | SS | MYALEPT | METRELEPTIN | 1 | Subcutaneous | LO505085 | 0 | 2.5 | MG | POWDER FOR INJECTION | |||||||
| 126229021 | 12622902 | 3 | SS | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 2000 MILLIGRAM DAILY; | U | 0 | 1000 | MG | TABLET | BID | |||||
| 126229021 | 12622902 | 4 | C | PRECOSE | ACARBOSE | 1 | 0 | TABLET | |||||||||||
| 126229021 | 12622902 | 5 | C | LOFIBRA | FENOFIBRATE | 1 | 0 | CAPSULE | |||||||||||
| 126229021 | 12622902 | 6 | C | LOFIBRA | FENOFIBRATE | 1 | 0 | CAPSULE | |||||||||||
| 126229021 | 12622902 | 7 | C | ZESTRIL | LISINOPRIL | 1 | 0 | TABLET | |||||||||||
| 126229021 | 12622902 | 8 | C | TENORMIN | ATENOLOL | 1 | 0 | TABLET | |||||||||||
| 126229021 | 12622902 | 9 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | 0 | TABLET | |||||||||||
| 126229021 | 12622902 | 10 | C | DULERA | FORMOTEROL FUMARATE DIHYDRATEMOMETASONE FUROATE | 1 | 0 | ||||||||||||
| 126229021 | 12622902 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | CAPSULE | |||||||||||
| 126229021 | 12622902 | 12 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 0 | TABLET | |||||||||||
| 126229021 | 12622902 | 13 | C | Folate | FOLATE SODIUM | 1 | 0 | TABLET | |||||||||||
| 126229021 | 12622902 | 14 | C | Omega 3 fish oil | FISH OILOMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
| 126229021 | 12622902 | 15 | C | Insulin Humulin Regular | 2 | 0 | |||||||||||||
| 126229021 | 12622902 | 16 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | TABLET | |||||||||||
| 126229021 | 12622902 | 17 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 126229021 | 12622902 | 18 | C | Amlactin | AMMONIUM LACTATE | 1 | 0 | CREAM | |||||||||||
| 126229021 | 12622902 | 19 | C | BACITRACIN ZINC. | BACITRACIN ZINC | 1 | 0 | OINTMENT | |||||||||||
| 126229021 | 12622902 | 20 | C | PERIDEX | CHLORHEXIDINE GLUCONATE | 1 | 0 | MOUTH WASH | |||||||||||
| 126229021 | 12622902 | 21 | C | DIPHENHYDRAMINE HYDROCHLORIDE with Zinc acetate | 2 | 0 | CREAM | ||||||||||||
| 126229021 | 12622902 | 22 | C | COLACE | DOCUSATE SODIUM | 1 | 0 | CAPSULE | |||||||||||
| 126229021 | 12622902 | 23 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 0 | NASAL SPRAY | |||||||||||
| 126229021 | 12622902 | 24 | C | NEURONTIN | GABAPENTIN | 1 | 0 | ||||||||||||
| 126229021 | 12622902 | 25 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | 0 | ||||||||||||
| 126229021 | 12622902 | 26 | C | NIZORAL | KETOCONAZOLE | 1 | 0 | CREAM | |||||||||||
| 126229021 | 12622902 | 27 | C | NIZORAL | KETOCONAZOLE | 1 | 0 | SHAMPOO | |||||||||||
| 126229021 | 12622902 | 28 | C | MOBIC | MELOXICAM | 1 | 0 | TABLET | |||||||||||
| 126229021 | 12622902 | 29 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 0 | CAPSULE | |||||||||||
| 126229021 | 12622902 | 30 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
| 126229021 | 12622902 | 31 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
| 126229021 | 12622902 | 32 | C | SILVADENE | SILVER SULFADIAZINE | 1 | 0 | CREAM | |||||||||||
| 126229021 | 12622902 | 33 | C | Diphenhydramine Hcl | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126229021 | 12622902 | 34 | C | GLUCAGON. | GLUCAGON | 1 | 0 | ||||||||||||
| 126229021 | 12622902 | 35 | C | ARISTOCORT | TRIAMCINOLONE DIACETATE | 1 | 0 | ||||||||||||
| 126229021 | 12622902 | 36 | C | ATENOLOL. | ATENOLOL | 1 | 0 | ||||||||||||
| 126229021 | 12622902 | 37 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126229021 | 12622902 | 1 | Dermatomyositis |
| 126229021 | 12622902 | 2 | Lipodystrophy acquired |
| 126229021 | 12622902 | 3 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126229021 | 12622902 | OT |
| 126229021 | 12622902 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126229021 | 12622902 | Abdominal pain upper | |
| 126229021 | 12622902 | Blood glucose increased | |
| 126229021 | 12622902 | Blood phosphorus increased | |
| 126229021 | 12622902 | Blood potassium decreased | |
| 126229021 | 12622902 | Dyspnoea | |
| 126229021 | 12622902 | Lactic acidosis | |
| 126229021 | 12622902 | Pancreatitis acute | |
| 126229021 | 12622902 | Tachycardia | |
| 126229021 | 12622902 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126229021 | 12622902 | 1 | 2016 | 0 | ||
| 126229021 | 12622902 | 2 | 20140822 | 0 |